Maintenance therapy in the treatment of sarcoma

Clin Adv Hematol Oncol. 2011 Oct;9(10):773-4.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use
  • Child
  • Disease-Free Survival
  • Doxorubicin / administration & dosage
  • Doxorubicin / therapeutic use
  • Humans
  • Ifosfamide / administration & dosage
  • Ifosfamide / therapeutic use
  • Neoplasm Metastasis
  • Osteosarcoma / drug therapy
  • Osteosarcoma / mortality
  • Osteosarcoma / pathology
  • Randomized Controlled Trials as Topic
  • Sarcoma / drug therapy*
  • Sarcoma / mortality
  • Sarcoma / pathology
  • Sirolimus / administration & dosage
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use
  • TOR Serine-Threonine Kinases / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • ridaforolimus
  • Doxorubicin
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Ifosfamide
  • Sirolimus